Jiangsu Lintex Advanced Materials
920106
BBK Test Systems
301598
Zhejiang Lanyu Digital Technology
301585
Shaanxi Kelong New Material Technology
920098
Sprint Precision Technologies
688605
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | 15.75%299.59M | -6.46%175.27M | 12.86%104.31M | -22.09%328.24M | -26.23%258.83M | -21.29%187.38M | -29.08%92.42M | -13.09%421.32M | 4.43%350.86M | -5.71%238.05M |
Refunds of taxes and levies | 71.39%71.91M | 114.21%66.76M | -28.19%13.52M | -32.10%62.56M | -47.25%41.96M | -26.36%31.17M | -36.94%18.83M | -16.16%92.13M | -20.29%79.55M | -49.96%42.32M |
Net deposit increase | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | --0 |
Net increase in borrowings from central bank | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | --0 |
Net increase in placements from other financial institutions | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | --0 |
Cash received from interests, fees and commissions | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | --0 |
Net increase in repurchase business capital | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | --0 |
Premiums received from original insurance contracts | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | --0 |
Net cash received from reinsurance business | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | --0 |
Net increase in deposits from policyholders | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | --0 |
Net increase in funds disbursed | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | --0 |
Net cash received from trading securities | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | --0 |
Cash received relating to other operating activities | -9.30%156.86M | -13.00%127.88M | -7.80%66.47M | -34.96%229.59M | -30.18%172.95M | 2.19%147M | 14.31%72.09M | 20.20%353M | 11.82%247.7M | -5.86%143.85M |
Adjustment items of operating cash inflws | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash inflows from operating activities | 11.53%528.36M | 1.19%369.91M | 0.52%184.29M | -28.40%620.39M | -30.14%473.74M | -13.83%365.54M | -17.87%183.34M | -2.46%866.44M | 3.17%678.1M | -13.40%424.22M |
Goods services cash paid | 62.59%196.61M | 59.00%114.44M | 0.07%37.15M | -23.24%149.41M | -17.44%120.92M | -26.34%71.98M | -42.27%37.12M | -32.88%194.64M | -19.07%146.47M | -36.52%97.72M |
Staff behalf paid | 32.47%102.21M | 33.83%67.7M | 24.34%31.04M | -10.04%100.92M | -4.71%77.16M | -6.29%50.59M | 4.92%24.96M | 12.45%112.18M | 9.08%80.97M | 10.62%53.98M |
All taxes paid | -0.26%11.98M | -25.45%8.8M | 3.81%6.33M | -9.42%16.3M | -2.68%12.01M | 39.43%11.81M | 12.93%6.09M | -37.46%17.99M | -46.24%12.34M | -59.98%8.47M |
Net loan and advance increase | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | --0 |
Net deposit in central bank and institutions | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | --0 |
Net lend capital | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | --0 |
Cash paid for fees and commissions | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | --0 |
Cash paid for indemnity of original insurance contract | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | --0 |
Policy dividend cash paid | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | --0 |
Cash paid relating to other operating activities | -2.78%170.59M | -12.73%129.41M | 28.77%84.85M | -36.35%225.57M | -37.72%175.48M | -7.63%148.29M | -5.62%65.9M | 27.12%354.4M | 19.92%281.74M | -0.42%160.54M |
Cash outflows from operating activities | 24.85%481.39M | 13.34%320.36M | 18.86%159.36M | -27.54%492.2M | -26.07%385.56M | -11.86%282.67M | -17.90%134.08M | -2.59%679.22M | 1.64%521.52M | -16.72%320.72M |
Net cash flows from operating activities | -46.73%46.98M | -40.22%49.54M | -49.40%24.93M | -31.53%128.19M | -43.69%88.18M | -19.93%82.87M | -17.79%49.26M | -1.99%187.22M | 8.60%156.58M | -1.16%103.5M |
Investing cash flow | ||||||||||
Cash received from disposal of investments | --0 | --0 | --0 | -89.68%20.64M | -89.82%20.64M | -89.82%20.64M | --0 | --200M | --202.67M | --202.67M |
Cash received from returns on investments | --0 | --0 | --0 | -99.85%4.09K | --10.29K | --10.29K | --0 | --2.67M | --0 | --0 |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 74.80%1.83M | -86.79%81.8K | 169.06%121.43K | 86.46%6.99M | -86.08%1.04M | -87.95%619.12K | -98.18%45.13K | 10.21%3.75M | 1,565.23%7.5M | 1,148.91%5.14M |
Net cash received from disposal of subsidiaries and other business units | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | --0 |
Cash received relating to other investing activities | -69.85%5.49M | -69.75%5.49M | --16.53K | 6,165,137.59%39.75M | 2,822,851.63%18.2M | 2,813,306.33%18.14M | --0 | -100.00%644.77 | -100.00%644.77 | -100.00%644.77 |
Cash inflows from investing activities | -81.67%7.31M | -85.87%5.57M | 205.68%137.96K | -67.36%67.38M | -81.02%39.9M | -81.04%39.41M | -99.98%45.13K | -43.98%206.42M | -55.19%210.18M | -43.11%207.81M |
Cash paid to acquire fixed assets intangible assets and other long-term assets | 22.67%556.39M | 17.45%350.85M | 52.06%175.01M | 18.68%640.07M | 4.07%453.58M | -7.26%298.71M | 28.87%115.09M | 81.45%539.3M | 85.59%435.83M | 153.64%322.09M |
Cash paid to acquire investments | -90.16%4M | -90.16%4M | -20.00%8M | 253.98%48.14M | 198.83%40.64M | 198.83%40.64M | -26.47%10M | --13.6M | --13.6M | --13.6M |
Net cash paid to acquire subsidiaries and other business units | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | --0 |
Impawned loan net increase | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | --0 |
Cash paid relating to other investing activities | --16.09M | --5.91M | --0 | 22.18%33.84M | --0 | --0 | --7.44M | -95.05%27.7M | -97.47%18.2M | -96.05%18.19M |
Cash outflows from investing activities | 16.64%576.48M | 6.31%360.75M | 38.09%183.01M | 24.36%722.05M | 5.69%494.22M | -4.11%339.35M | 28.78%132.53M | -32.27%580.6M | -51.03%467.63M | -39.71%353.88M |
Net cash flows from investing activities | -25.28%-569.17M | -18.42%-355.18M | -38.03%-182.88M | -74.96%-654.67M | -76.47%-454.33M | -105.34%-299.94M | -229.59%-132.49M | 23.44%-374.18M | 47.01%-257.45M | 34.11%-146.07M |
Financing cash flow | ||||||||||
Cash received from capital contributions | --999K | --999K | --0 | --0 | --0 | --0 | --0 | -99.18%8M | -99.17%8M | -99.17%8M |
-Including: Cash received from capital contributions by minority shareholders of subsidiaries | --999K | --999K | --0 | --0 | --0 | --0 | --0 | 3.14%8M | --8M | --0 |
Cash from borrowing | 28.86%499.96M | 35.89%387M | 44.80%189.69M | 56.45%509.78M | 54.07%388M | 62.89%284.79M | 123.64%131M | 586.11%325.83M | 492.69%251.83M | 311.47%174.83M |
Cash received relating to other financing activities | --410M | --120M | --5.88M | 429.59%50M | --0 | --0 | --0 | -16.84%9.44M | -25.52%7.44M | --0 |
Cash inflows from financing activities | 134.78%910.95M | 78.38%508M | 49.29%195.57M | 63.07%559.78M | 45.17%388M | 55.77%284.79M | 123.64%131M | -66.64%343.27M | -73.67%267.27M | -81.99%182.83M |
Borrowing repayment | 79.35%247.56M | 31.11%180.12M | --70.6M | -14.78%188.54M | -8.34%138.04M | 163.56%137.38M | --0 | -21.51%221.24M | -42.08%150.6M | -79.95%52.12M |
Dividend interest payment | 254.34%22.5M | 139.34%9.94M | 264.00%6.41M | -70.05%11.29M | -82.49%6.35M | -86.12%4.15M | 65.56%1.76M | -24.76%37.69M | -17.19%36.27M | -8.23%29.91M |
-Including:Cash payments for dividends or profit to minority shareholders | --0 | --0 | --0 | ---- | --0 | --0 | --0 | ---- | ---- | --0 |
Cash payments relating to other financing activities | 1,415.06%54.17M | 25,536.12%23.6M | --0 | -82.13%4.46M | -84.22%3.58M | -99.59%92.04K | --0 | -8.23%24.96M | -19.07%22.66M | -18.91%22.66M |
Cash outflows from financing activities | 119.13%324.23M | 50.86%213.65M | 4,275.74%77M | -28.04%204.29M | -29.38%147.96M | 35.27%141.62M | -44.17%1.76M | -20.96%283.88M | -36.85%209.53M | -67.34%104.7M |
Net cash flows from financing activities | 144.43%586.72M | 105.60%294.34M | -8.26%118.57M | 498.58%355.49M | 315.71%240.04M | 83.24%143.16M | 133.19%129.24M | -91.13%59.39M | -91.55%57.74M | -88.75%78.13M |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | 109.76%1.24M | 36.19%-4.88M | 2.21%-2.11M | -191.93%-9.58M | 44.41%-12.69M | 66.05%-7.65M | 80.92%-2.15M | 176.35%10.42M | -302.92%-22.84M | -368.68%-22.53M |
Adjustment items effecting cash and cash equivalents | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---0.01 |
Net increase in cash and cash equivalents | 147.38%65.77M | 80.16%-16.18M | -194.58%-41.48M | -54.13%-180.56M | -110.42%-138.81M | -725.75%-81.55M | -78.74%43.86M | -132.67%-117.15M | -119.65%-65.97M | -97.72%13.03M |
Add:Begin period cash and cash equivalents | -58.73%126.86M | -58.74%126.85M | -58.73%126.86M | -27.59%307.41M | -27.59%307.41M | -27.59%307.41M | -27.59%307.41M | 543.05%424.56M | 543.05%424.56M | 543.05%424.56M |
End period cash equivalent | 14.25%192.63M | -51.00%110.67M | -75.70%85.37M | -58.74%126.85M | -52.98%168.6M | -48.39%225.86M | -44.32%351.27M | -27.59%307.41M | -10.75%358.59M | -31.47%437.59M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.